Texoma Vintage -
Classic Car Club Show at Denison, Texas, with photos by Sheriff Terry
Box, Carla Freelen Burnett and Kerry Ferguson. Video slideshow by Brian
Bearden for Terry Box and prize-winning Purplelicious, which received a
Best of Class award at Denison. Brian Burnett's car also earned Best of
Class. The 41st-annual show was a benefit for Meals on Wheels of Texoma
and the Court Appointed Special Advocates (CASA).
The Senegalese artist Youssou N’Dour and Finnish composer Kaija Saariaho today received the 2013 Polar Music Prize from His Majesty King Carl XVI Gustaf of Sweden at a gala ceremony at the Stockholm Concert Hall.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62402-polar-music-prize-2013
As part of its mission to help cat owners solve tough litter box odors, Tidy Cats® recently gave one cat owner a once-in-a-lifetime experience: a Littervention. Devoted cat owner Ricci Rivera, together with his cat named Bella of San Tan Valley, AZ, were named the Grand Prize Winner among hundreds of entries to the Tidy Cats® with Glade™ Tough Odor Solutions Littervention Contest. In his entry, Rivera attributed his need for a Littervention due to his home’s open floor plan, which can carry overwhelming litter box odors throughout the house. As the Grand Prize Winner, Rivera received a visit from the Tidy Cats® “Scentsational Littervention” Crew, including cat-loving home and design expert and current co-host of Love it or List it, Too Jillian Harris, who showed him how to neutralize even the toughest litter box odors and how to keep a clean litter box area and welcoming home.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62803-tidy-cats-jillian-harris-give-one-owner-littervention-of-lifetime
Zhang Xinyuan, born in Wuhan, Hubei Province, graduated from the Central Academy of Drama in 2012, BA of
performance. In 2008, her self-made images ignited online communities in China. Heavy-eyebrowed and flame-lipped,
but also chaste and ethereal, her images are both polarized and harmonious, no wonder they received so explosive
acclaiming and spreading.
From then on, Zhang Xinyuan becomes a fashion icon and favored by various media and industries, her images even
initiated a tide of retro-styling in the youths of China. Instead of stopping on that, Miss Zhang keeps on sharpening her
art language by the grindstones of her unique aesthetic taste, say-no-to-vulgarity attitude, and oriental wisdom. With the
love to public art, Miss Zhang has crossover-cooperated with various artists and stylists, and become a rising star of
arts, which made her the cover star of I-D, a famous British fashion magazine, in Mar.2012. The next month,Apr.2012,
her high-profile photo album Girlfriend On The Cliff became the top one seller in the Amazon list of photographic books,
and one of the best-sellers of Motie Company, who has published this book. Sold out in various online shopping sites,
Dream Raider studio and Motie Company printed other batches of copies, all of which had been sold out now.
Zhang Xinyuan, born in Wuhan, Hubei Province, graduated from the Central Academy of Drama in 2012, BA of
performance. In 2008, her self-made images ignited online communities in China. Heavy-eyebrowed and flame-lipped,
but also chaste and ethereal, her images are both polarized and harmonious, no wonder they received so explosive
acclaiming and spreading.
From then on, Zhang Xinyuan becomes a fashion icon and favored by various media and industries, her images even
initiated a tide of retro-styling in the youths of China. Instead of stopping on that, Miss Zhang keeps on sharpening her
art language by the grindstones of her unique aesthetic taste, say-no-to-vulgarity attitude, and oriental wisdom. With the
love to public art, Miss Zhang has crossover-cooperated with various artists and stylists, and become a rising star of
arts, which made her the cover star of I-D, a famous British fashion magazine, in Mar.2012. The next month,Apr.2012,
her high-profile photo album Girlfriend On The Cliff became the top one seller in the Amazon list of photographic books,
and one of the best-sellers of Motie Company, who has published this book. Sold out in various online shopping sites,
Dream Raider studio and Motie Company printed other batches of copies, all of which had been sold out now.
Zhang Xinyuan, born in Wuhan, Hubei Province, graduated from the Central Academy of Drama in 2012, BA of
performance. In 2008, her self-made images ignited online communities in China. Heavy-eyebrowed and flame-lipped,
but also chaste and ethereal, her images are both polarized and harmonious, no wonder they received so explosive
acclaiming and spreading.
From then on, Zhang Xinyuan becomes a fashion icon and favored by various media and industries, her images even
initiated a tide of retro-styling in the youths of China. Instead of stopping on that, Miss Zhang keeps on sharpening her
art language by the grindstones of her unique aesthetic taste, say-no-to-vulgarity attitude, and oriental wisdom. With the
love to public art, Miss Zhang has crossover-cooperated with various artists and stylists, and become a rising star of
arts, which made her the cover star of I-D, a famous British fashion magazine, in Mar.2012. The next month,Apr.2012,
her high-profile photo album Girlfriend On The Cliff became the top one seller in the Amazon list of photographic books,
and one of the best-sellers of Motie Company, who has published this book. Sold out in various online shopping sites,
Dream Raider studio and Motie Company printed other batches of copies, all of which had been sold out now.
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
The Energy Globe World Award goes to Nicaragua! With a happy “Muchas Gracias”, Martha Veronica Rocha received the 13 kg bronze statue for her organization FUPROSOMUNIC in the studio of the Austrian Broadcasting Corporation Salzburg. Salzburg Governor Wilfried Haslauer, Mayor Heinz Schaden, Cardinal of the Roman Catholic Church Peter Turkson and Energy Globe Founder Wolfgang Neumann presented the award. Austria also excelled as a category winner in “Fire.” Wolfgang Neumann: “These projects are a strong signal – they show the world that our environmental problems can be solved.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64995-energy-globe-world-award-solar-women
Visit: http://www.melogia.com
Buy: https://itunes.apple.com/us/artist/sarantos/id784136489?ign-mpt=uo%3D4
Song: "I'd Give Anything" - "This is a harsh rock song about a desperate man who remembers the love he used to have," says Sarantos. "He would give anything for his heart to be happy." Sarantos strives to inspire people with his rock songs and lyrics. Music is always on his mind and Sarantos has written over 2,000 songs. Sarantos' music has received rave reviews so far from industry insiders, and he relishes this chance to pursue his lifelong dream. His unique sound has been best described by industry insiders as "An emotionally powerful vocal style masterfully united with music that is a fusion of classic 80s rock blended with modern soft rock and pop music!"
A new music song will be released the 1st Tuesday of every month to tease his fans. Then a new music video on the 2nd Tuesday of every month, a new Funny video of the month on the 3rd Tuesday of every month and a new Whiteboard video on the 4th Tuesday of every month. This will go on for the entire year! The CD will then be released on November 18th, 2014.
Sarantos has always been inclined to help people in need and is proud to launch this CD as a way to donate a significant portion of proceeds to charity, hopefully inspiring other artists to do the same. The 11 charities chosen for each album song include American Lung Association, Make-a-wish Foundation, American Heart Association, St Jude's, Hellenic Academy, ASERF, American Red Cross, Children's Hospital of Chicago, Chicago Medical School, Thanioton Society & the Cystic Fibrosis Foundation.
Conntect With Sarantos On Facebook:
https://www.facebook.com/Sarantosmelogia
Connect With Sarantos On Twitter:
http://www.twitter.com/sarantosmelogia
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.
The ClearSight system is a noninvasive monitor that provides clinicians access to valuable blood volume and blood flow information for patients at moderate or high risk of post-surgical complications, in whom invasive monitoring would not be used.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256451-edwards-fda-clearance-for-noninvasive-hemodynamic-monitoring-system/
